Diabetes Mellitus (ISSN:2072-0351): Monthly Peer-Reviewed Scopus-Indexed Journal for Diabetes Research
Diabetes Mellitus (ISSN:2072-0351) represents one of the most critical public health challenges of the modern era. Characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both, this metabolic disorder affects hundreds of millions of individuals globally. Unmanaged high blood sugar levels precipitate severe vascular, renal, neural, and ocular complications. Addressing this global health burden requires continuous, rigorous scientific inquiry, clinical innovation, and evidence-based medicine.
To translate laboratory breakthroughs into frontline patient care, the scientific community relies on peer-reviewed literature. The platform hosted at Diabetes Mellitus (ISSN:2072-0351) serves as an authoritative hub for academic communication. As a monthly peer-reviewed publication venue indexed in Scopus, the journal connects basic scientists, clinical endocrinologists, and healthcare providers dedicated to advancing metabolic health.
The Imperative of Monthly Peer-Reviewed Diabetes Research
Modern clinical endocrinology moves forward through rigorous scientific verification. In an age of rapid medical innovation, evidence-based studies published in Diabetes Mellitus (ISSN:2072-0351) provide the foundation for updated diagnostic criteria, safe pharmacological therapies, and improved patient care protocols.
Uncovering Pathophysiological Mechanisms
The metabolic pathways driving metabolic disease are complex and multifaceted:
● Type 1 Diabetes: Research focuses heavily on autoimmune mechanisms, T-cell-mediated beta-cell destruction, genetic susceptibility markers, and potential immunomodulatory therapies.
● Type 2 Diabetes: Studies investigate peripheral insulin resistance, gut microbiome dysbiosis, chronic tissue inflammation, and progressive beta-cell dysfunction.
● Gestational Diabetes & Rare Forms: Research continues to elucidate placental hormone dynamics and monogenic mutations governing pancreatic development.
Rapid Dissemination via Monthly Publication
Because clinical research evolves rapidly, monthly publication cycles ensure that novel clinical trials, diagnostic advancements, and epidemiological findings reach global audiences without unnecessary delays. This predictable, frequent release schedule allows researchers to cite up-to-date data and assists clinicians in adopting verified therapies faster.
Strategic Significance of Scopus Indexing for Authors
When selecting a medical journal for manuscript submission, indexing status plays a central role in determining an article’s reach, discoverability, and academic weight.
1. Global Visibility and Reach
Scopus is one of the world's largest curated abstract and citation databases. Articles published in Diabetes Mellitus (ISSN:2072-0351) are indexed systematically, allowing researchers across the globe to easily locate, read, and cite the work.
2. Standardized Metrics and Impact Tracking
Authors benefit from clear bibliometric tracking. Scopus indexing enables researchers to monitor citation counts, co-authorship networks, and field-weighted citation impacts, providing verifiable evidence of research influence.
3. Institutional and Funding Alignment
Academic institutions, funding agencies, and medical faculties worldwide evaluate publication output based on recognized database indexings. Publishing in a Scopus-indexed journal supports career progression, grant applications, and institutional ranking criteria.
Key Research Scope and Manuscript Domains
Research into Diabetes Mellitus (ISSN:2072-0351) spans diverse biological, clinical, and technological domains. The journal maintains a comprehensive scope to accommodate original research, reviews, case studies, and clinical reports across multiple disciplines.
Type 1 and Type 2 Pathophysiology
Understanding the molecular and metabolic drivers of beta-cell dysfunction, autoantibody development, peripheral insulin resistance, and metabolic syndrome remains central to clinical management. The journal welcomes empirical studies that shed light on gene-environment interactions, epigenetic markers, and cellular signaling networks.
Cardiorenal and Microvascular Complications
Long-term management requires preventing end-organ damage. Key priorities for clinical literature include research addressing:
● Diabetic Nephropathy & Renal Health: Biomarkers for early renal decline and novel renoprotective agents like SGLT2 inhibitors and non-steroidal MRAs.
● Cardiovascular Outcomes: Interventions targeting atherogenic dyslipidemia, endothelial dysfunction, and heart failure.
● Neuropathy and Retinopathy: Diagnostic advancements and therapeutic modalities for neuropathic pain and microvascular retinal lesions.
Diabetes Technology and Precision Health
Digital tools are reshaping diabetes care. The journal invites manuscripts focusing on automated insulin delivery (AID) systems, continuous glucose monitoring (CGM) analytics, smart drug delivery systems, and artificial intelligence models for glycemic prediction.
Value Proposition for the Scientific Community
Publishing in an established open-access journal offers distinct advantages across the healthcare ecosystem.
Target Audience | Core Value Proposition | Practical Outcome |
Research Authors | Double-blind peer review and Scopus indexing visibility. | Increased citations, global reach, and academic credibility. |
Clinicians & Endocrinologists | Access to monthly peer-reviewed therapeutic updates. | Informs evidence-based bedside practice and treatment plans. |
Healthcare Academics | Reliable repository for systemic literature synthesis. | Supports educational curricula and research development. |
Public Health Analysts | Empirical data on disease prevalence and outcomes. | Guides regional healthcare policies and prevention strategies. |
Workflow: From Manuscript Submission to Publication
To ensure a seamless experience for contributing scholars, the editorial framework adheres to structured manuscript handling processes.
Preparation and Submission: Authors format their work in accordance with standardized reporting criteria (e.g., CONSORT, PRISMA) and submit manuscripts via the online submission system.
Editorial Pre-Check: The editorial team screens submissions for originality, scope alignment, and ethical standards.
Peer Review: Independent reviewers evaluate the research for scientific accuracy, depth, and methodological clarity.
Revision and Decision: Authors refine their papers based on constructive feedback prior to final acceptance.
Monthly Open Access Dissemination: Accepted papers are published monthly under Gold Open Access, ensuring immediate, unrestricted global availability.
Advance Your Research with Diabetes Mellitus (ISSN:2072-0351)
Contributing to the scientific body of knowledge on Diabetes Mellitus (ISSN:2072-0351) is critical to improving patient care and advancing global metabolic health. Researchers, clinicians, and academic teams are invited to share their research with an international audience.
Visit Diabetes Mellitus (ISSN:2072-0351) to explore the latest open-access articles, review submission guidelines, and submit your manuscript to a monthly peer-reviewed, Scopus-indexed journal site.
Frequently Asked Questions (FAQs)
Q1: What is the ISSN for the Diabetes Mellitus journal?
A: The official International Standard Serial Number for the journal is Diabetes Mellitus (ISSN:2072-0351).
Q2: How frequently is the journal published?
A: The journal operates on a monthly publication schedule, ensuring rapid dissemination of peer-reviewed research.
Q3: Is Diabetes Mellitus (ISSN:2072-0351) indexed in Scopus?
A: Yes, the journal is indexed in Scopus, providing global discoverability, citation tracking, and institutional recognition for published articles.
Q4: What manuscript types are accepted for publication?
A: The journal accepts original research articles, systematic reviews, meta-analyses, clinical trial reports, short communications, and case studies spanning endocrinology and metabolic diseases.
Q5: How can authors submit their manuscripts?
A: Authors can submit their manuscripts, cover letters, and supplementary data directly through the online submission system at https://diabetesmellitusjournal.com/.
Comments